Showing results (1051-1060 of 2,659) with videos related to
Sort By:
Pageof 266
Hypertension (Dallas, Tex. : 1979)|September 21, 2005
Relaxin increases cardiac output and reduces systemic arterial load in hypertensive ratsDan O Debrah, Kirk P Conrad, Arundhathi Jeyabalan, et al.Endocrinology|June 17, 2004
Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant ratsKirk P Conrad, Dan O Debrah, Jackie Novak, et al.Annals of the New York Academy of Sciences|June 16, 2005
Recombinant human relaxin (rhRLX) modifies systemic arterial properties in conscious rats irrespective of gender, but in a biphasic fashionDan O Debrah, Kirk P Conrad, Jackie Novak, et al.The Journal of Thoracic and Cardiovascular Surgery|December 2, 2004
Supraventricular tachyarrhythmias in Ebstein anomaly: management and outcomeAnant Khositseth, Gordon K Danielson, Joseph A Dearani, et al.The Journal of Thoracic and Cardiovascular Surgery|December 1, 1976
Ebstein's malformation. Surgical experience at the Mayo ClinicR C McFaul, Z Davis, E R Giuliani, et al.Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society|April 28, 2007
Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancerH Danielson, A Kokkola, T Kiviluoto, et al.Journal of Medical Economics|January 24, 2023
An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United StatesChristopher Raspin, Edward Faught, Jeanne Armand, et al.Biochemistry|November 18, 2017
Effect of an Imposed Contact on Secondary Structure in the Denatured State of Yeast Iso-1-cytochrome cTravis A Danielson, Jessica M Stine, Tanveer A Dar, et al.The American Journal of Cardiology|September 1, 1977
Intravenous diazoxide therapy in hypertensive crisisW J McDonald, G Smith, J W Woods, et al.Proceedings of the National Academy of Sciences of the United States of America|December 17, 2008
Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenasesQing Jiang, Xinmin Yin, Markus A Lill, et al.Pageof 266